Pathology White cell disorders I - Zaloga Flashcards
myeloid tissues
- include bone marrow and derived cells
- bone marrow is “house” for all progenitor cells
lymphoid tissues
-include thymus, spleen, lymph nodes, MALT and resident cells
where does primary hematopoiesis occur?
-bone marrow and thymus**
where does secondary hematopoiesis occur?
-spleen, lymph nodes, tonsils, peyer’s patch
HSC vs. multipotent progenitors
- HSC - pluripotent, can develop into any mature cell, self renewal, no surface markers (cannot identify), used in transplants
- multipotent progenitor - go down a cell lineage (terminal differentiated), less self renewal, higher proliferation
- differentiation driven by cytokines/growth factors
- increase division as cell matures –> change in surface markers
- unregulated clonal expansion with hematopoietic tumors
what does G-CSF and IL-5 do?
- G-CSF –> stimulate granulocyte precursors
- IL-5 –> stimulate eosinophilia
sinusoids
-where formed elements enter the blood from the marrow
marrow morphology
- myeloid cells (granulocytes) paratrebecular
- RBCs surround Macs to get Fe
- megakaryocytes surround next to sinusoids to release platelets
leukoerythroblastosis –> immature precursors released into blood
leukopenia
- low WBC count
- neutropenia most common**
- lymphopenia less common (in HIV, steroids, autoimmune, viral infections)
proliferative disorders
- expansion of leukocytes
1. reactive - has inflammation/infection
2. neoplastic - no inflammation, just proliferation forming tumor
neutropenia aka agranulocytosis
- risk of hematologic disease or increased risk for infection**
- see ulcerating lesions of mucous membranes from bacterial/fungal infection
- risk for deep fungal infections by candida and aspergillum
- massive organism growth, little leukocyte response
levels of neutropenia**
Mild: 1.0-1.5×109 neutrophils/L
Moderate: 0.5-0.9×109 neutrophils/L
Severe: <0.5×109 neutrophils/L
downey cells**
- activated lymphocytes reacting EBV, CMV**
- atypical lymphocytes
causes of neutropenia
- ineffective/inadequate erythropoiesis
- suppression of HSC
- drug suppression of precursors –> drug toxicity most common cause** (chemo, alkylating agents, sulfonamides, pmenothiazines) –> high risk of infection**
- ineffective hematopoiesis from megaloblastic anemia –> apoptosis
- inherited gene defects that impair granulocyte proliferation
- increased destruction or sequestration –> from severe infection or splenomegaly**
- increased destruction of neutrophils –> hyper cellular marrow*
- agranulocytosis (from overwhelming infection) –> hypocellular marrow*
reactive proliferations of WBC –> leukocytosis
- increase in WBC count
- inflammation, infection, hypoxia increase release from storage pool
- exercise and catecholamines increase demargination (break off of vessel walls)
- cortisol decreases extravasation into tissues